SCHEMBL20977652

SCHEMBL20977652

c1ccc(-c2cccc(-c3cccc(-c4nc(-c5ccc6c(c5)oc5ccccc56)cc(-c5ccc6c(c5)oc5ccccc56)n4)c3)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
MAPT P10636 5/20 0.46
ALDH1A1 P00352 4/20 0.46
HPGD P15428 4/20 0.46
KDM4E B2RXH2 3/20 0.46
LMNA P02545 2/20 0.46
HCRTR1 O43613 1/20 0.45
PLA2G2A P14555 3/20 0.44
PLA2G4A P47712 3/20 0.44
MMP12 P39900 1/20 0.43
MMP13 P45452 1/20 0.43
GLA P06280 1/20 0.43
AHR P35869 2/20 0.42
PLA2G10 O15496 1/20 0.42
NTSR1 P30989 1/20 0.41
TTR P02766 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20977653 1.00 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL20977650 1.00 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL20977654 1.00 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL20977644 1.00 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL20977645 1.00 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21029097 0.99 MEN1 (0.49) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21028830 0.99 MEN1 (0.49) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21028969 0.99 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL20977651 0.99 MEN1 (0.49) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21029096 0.99 MEN1 (0.49) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11706975-B2 Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display apparatus SAMSUNG SDI CO., LTD. (KR) 2023-07-18 US disclosed
US-11706975-B2 Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display apparatus SAMSUNG SDI CO., LTD. (KR) 2023-07-18 US disclosed
US-20190326518-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-10-24 US disclosed
US-20190280211-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-09-12 US disclosed
US-20190181351-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-06-13 US disclosed
US-20190165280-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY APPARATUS SAMSUNG SDI CO., LTD. (KR) 2019-05-30 US disclosed
EP-3480278-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY APPARATUS Samsung SDI Co., Ltd (KR) 2019-05-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11706975-B2 Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display apparatus OXER1, OCIAD1, OR10J3 MEN1 2792/4885KMT2A 4120/4885MAPT 1973/4885
US-20190165280-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY APPARATUS OXER1, OCIAD1, OR10J3 MEN1 2792/4885KMT2A 4120/4885MAPT 1973/4885
US-20190181351-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE OCIAD2, OCIAD1, OR10J3 MEN1 2698/4885KMT2A 3784/4885MAPT 1944/4885
US-20190280211-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE ALDH1A2, AOX1, AOC3 MEN1 2814/4885KMT2A 4221/4885MAPT 2170/4885
US-20190326518-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE AOX1, ALDH1A2, AOC3 MEN1 2713/4885KMT2A 4118/4885MAPT 2395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.